Activity Stream
@moatrx
• one week ago
Posted a new blog:
GCC PNH LAUNCH READINESS
GCC PNH LAUNCH READINESS
SFDA registration ahead of iptacopan, not differentiation from entrenched anti-C5 therapy, will decide GCC PNH launch success.
Eculizumab and ravulizumab are...



